Trio of Indian pharmaceuticals millionaires launched 130 oncology generics [Taj Pharma] — chemotherapy drugs

Owners of Taj Pharmaceuticals have launched 130 innovative oncology to increase patient access their options for chemotherapy drugs

Mr.Shantanu Singh, Abhishek Singh, Priyanka Singh directors of Taj Pharmaceuticals Mumbai

Indian pharmaceuticals businessmen Abhishek Singh, Taj Pharmaceuticals Limited and Priyanka Singh could be in for a major windfall as one of Indian’s leading oncology care division manufacturing groups old unit is to be put up for sale in a deal that could net its owners north of £2.5 million.

This same in will lead to a further expansion of newly built Taj Oncology (chemotherapy drugs) Unit based in the Indian Territory; Sources have not confirmed exact details of such new venture; However, the move could be looked at venturing in the regulated markets of oncology products via an EMA, EU GMP regulated infrastructure with Oncology Section — Tablets, Capsules, Liquid and Lyophilized Injectables all under single unit.

Sources confirmed a Press Association report yesterday that the owners of Taj Pharmaceuticals — including Dr.Ranveer Kumar Singh (Chairman), Mr Abhishek Singh (Director), Priyanks Singh and Shantanu Singh (Executive Director) — have mandated investment banks and private equity holders to assess their options, the most likely of which is a sale.

The businessmen own Taj Pharmaceuticals Oncology Unit through their private investment vehicle Singh Investments SPA, and a formal sale process could be kicked off within weeks.

It is thought that several buyers have already expressed an interest, but only offers higher than £2.5 million are being taken seriously.

Dr.Ranvir Kumar Singh and Abhishek Singh (Director) and Priyanks Singh are close associates and have been involved in a number of ventures together, including ownership of a stake in several pharmaceuticals manufacturing units which they sold in 2014.

Trio sibling directors are best known here for their involvement in Russia and CIS markets, mainly, Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russian Federation, Tajikistan, Turkmenistan, and Uzbekistan. Ms Priyanka Singh is one of the partners behind Russia and CIS front, with more than 500 registered pharmaceutical products in state owned approx 1300–1800 state owned pharmacies in CIS nations; which gives vast reach to the anti-cancer products and Mr Shantanu Singh for his ownership of national distribution channel cooperation’s “stazs” such based at Saint Petersburg.

Chemotherapy drug patients

Taj Pharmaceuticals Oncology division currently boasts over 20 anti-cancer drug hospitals in Russia and CIS nations that house 11,000 chemotherapy patients people and employ 17,000 staff; who could be in severe drug shortage and budgetary constrains; if such chemotherapy drugs has to be purchased from the open market at retain prices; making such chemotherapy centers to be non-viable for poor and needy patients in India.

Latest accounts filed with Ministry for Economic Development of the Russian Federation show that Taj Pharma Russia’s turnover increased 5.3 per cent to £1.9 million in 2016, with operating profit coming in 5.6 per cent higher at £1.3 million.

The Indian pharmaceuticals trio Mr.Abhishek Singh, Mr.Shantanu Singh and Priyanka Singh first invested in Taj Pharmaceuticals Oncology Division in 2004, a year after the company was set up by father Dr Ranvir Singh, and are in line for a bumper payday if a deal goes ahead and a further expansion into bigger and better infrastructure with regulatory approvals.

Its attraction to a potential buyer for old oncology division, likely to be a private equity firm, is the fact that Taj Pharma’s primary focus is on privately-paying residents.

Chemotherapy drugs — Taj Pharmaceuticals

This means it is less beholden to local authority funding, which has plummeted in recent years, piling pressure on the wider sector.

Taj Pharmaceuticals chemotherapy division paid off a £0.9 million debt five years ago through the sale and leaseback of 2 Oncology care hospitals in Saint Petersburg to a property investment business, Crosswell International, which was backed by private investors at Moscow.

[Taj Pharmaceuticals] | {Taj Pharmaceuticals News} | Healthcare Company Chemotherapy drugs

Taj Pharmaceuticals News a Mumbai-based leading generic pharmaceutical company. Taj Pharmaceuticals is one of the leading generic pharmaceutical company in India. Taj Pharma is an enrolled medicate producing office with a great investigation record Chemotherapy drugs. Taj Pharmaceutical News & articles published daily. Taj Pharmaceuticals Directors team include Priyanka Singh, Abhishek Singh. Abhishek Taj Pharma is CEO, member of Taj Pharmaceutical Directors since January 2010. Includes news on pharmaceutical companies, mergers and acquisitions, drug development, export and import of drugs, legislation, advertising and influence

Taj Pharma Opens Chemotherapy Plant in Daman With Rs 100 Cr Investment

The Oncology Plant will cater exclusively to Oncology products. Taj Phamra group is present in over 40 countries and has around 6,000 employees across 15 plants.

The Oncology Plant — Taj Pharmaceuticals Limited

Taj Pharmaceuticals India Formulations, a subsidiary of India Drug Company company Taj Pharma Group, has opened its first R&D and pharmaceutical manufacturing facility with an initial investment of Rs 100 crore in Daman. The company plans to produce anti-cancer products oral solid dosage forms, including anti-cancer tablets, anti-cancer capsules, anti-cancer hard gelatin capsules,anti-cancer Liquid Injections and anti-cancer Lyophilized Injections. This would be one stop for 130 oncology products which will cover major type of anti-cancers.

“This is only the first step. We plan to invest more in Oncology Segement,” Taj Pharma Group director Abhishek Singh said on Wednesday.

The group is present in over 40 countries and has around 6,000 employees across 15 plants, 10 R&D centres and 33 affiliated companies, according to the company.

Labels: Mumbai FDA approves chemotherapy drugs unit taj directors Taj Pharmaceuticals cancer drug generic chemotherapy injections generic cancer sold chemotherapy mumbai company granted licence Taj Ahmedabad Taj Pharma Mumbai generic cancer approved USFDA inspection chemotherapy Mumbai news National chemotherapy News India chemotherapy News Breaking chemotherapy News India Today’s national news Latest national news National news headlines News chemotherapy Maharashtra News chemotherapy Mumbai News

Taj Pharmaceuticals | Pharmaceutical Company India | {Taj Pharma}

Taj Pharmaceuticals | Pharmaceutical Company India | Taj Pharma

India is on its way to becoming one of the biggest pharmaceutical producers in the world and many companies import their medicines and other pharmaceuticals from India. The reason being quality medicine being produced at cheaper rates and the comparative lack of red tape means better distribution and taxation policies in the country.

Taj Pharmaceuticals is one of the most prominent Pharma companies in the country and has been ever expansive, becoming a major pharmaceutical force in more than 40 countries across the globe. Taj Pharma is an all-encompassing company with facilities dedicated to research and development, testing and drug manufacturing. As an aspiring leader in pharmacology and pharmaceuticals, Taj Pharma maintains and excels the absolute highest industry standards, which is evident by the number of countries willingly importing their product.

Taj Pharma is a composite of all the above-mentioned operations. The company is wholly dedicated to improving the quality of life of the people dependent on their products for survival. They have operations in every major market in the world and their products are under constant scrutiny by the various regulating bodies all over the world. The stringent multi-level internal quality control is what helps Taj Pharmaceuticals manufacture the highest quality products. Their manufacturing facilities, located in Valsad, Gujarat, and Raigarh, Maharashtra are WHO-GMP approved and subjected to regular inspections by the internal quality control team and the Managing Director (MD). This dedication to maintaining and exceeding quality regulations is what sets them apart from their peers.

Their products cover a plethora of generic and branded compositions catering to a multitude of consumers all over the world. The exemplary work done by Taj Pharmaceuticals(Reviews) has made them a trusted household name. They are constantly striving for excellence which is evident by their Research and Development facilities which are always willing to tackle new challenges.

Taj Pharma is not just a pharmaceuticals company. It is a vision; a vision to provide quality health care for everyone, to alleviate the suffering of people and to promote excellence in all spheres by giving access to the best and most well-researched products modern science has to offer says Abhishek Taj Pharma.

So, How Many People You think Have Diabetes in India? — Shantanu Singh {Taj Pharma}

(hint: its more than the population of England) — An Initial investigation into diabetes illustrates.

suggest a diabetic patient to consider a natural way of controlling diabetes

An unbelievable, 7.2 crore people have diabetes in India! And, they are staring at the medicines with side-effects and the artificial sugar as their last hope.

Fortunately, we live in the motherland of Yoga and Ayurveda. And, they can choose a natural way to control Diabetes.

In Sanskrit, diabetes is called ‘Prameha’, and its a disease which causes all three ‘doshas’ (Pitta, Vata and Kapha) to go out of balance. That’s why Botany Bay Herbs created a herbal medicine that works on all three ‘doshas’ using three powerful herbs with no side-effects. Learn more on our website.

I think these 7.2 crore people should consider choosing a ‘zero side-effect’ natural remedy, and yoga to control diabetes.

If you agree, suggest a diabetic patient to consider a natural way of controlling diabetes. Read further at www.tajpharma..com

Lastly, some Ayurveda trivia for the day:

‘Ayur’ means life and ‘Veda’ means knowledge.

Live well,

Shantanu Singh,

Taj Pharmaceuticals Ltd. Mumbai

* population of UK is 66 million (6.6 crore)

# source of information for diabetic population of India- International Diabetes Foundation

Labels: Shantanu Singh {Taj Pharma}, Shantanu Singh, Taj Pharmaceuticals Ltd. Mumbai, Yoga and Ayurveda, artificial sugar, controlling diabetes, Diabetes in India

NIH conducts research on dietary supplements